Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [3]. Core Views - The company reported a revenue of 11.8 billion yuan for 2024, reflecting a year-on-year increase of 5.3%, while net profit decreased by 20.8% to 1.3 billion yuan. The Q4 revenue was 3.48 billion yuan, up 9.8% year-on-year, but net profit fell by 43.2% to 240 million yuan [1]. - The company's ODM (Original Design Manufacturer) and OBM (Original Brand Manufacturer) revenues showed contrasting trends, with ODM revenue declining slightly by 0.3% to 9.32 billion yuan, while OBM revenue increased by 34.0% to 2.48 billion yuan. In H2, ODM and OBM revenues grew by 9.7% and 13.4% respectively [1]. - The company is experiencing a recovery in its ODM business, particularly in the Chinese market, where revenue increased by 49.6% in H2. However, the European market is facing challenges due to regulations on disposable products [1][2]. - The gross margin for 2024 decreased by 3.9 percentage points to 36.9%, attributed to changes in product mix and rising labor costs. R&D expenses reached 1.57 billion yuan, representing 13.3% of revenue, as the company increased investment in atomization medical and HNB (Heated Not Burned) products [2]. - The HNB market is expected to expand, with potential growth driven by new product launches and market entry strategies. The company is optimistic about its hilo product line following successful trials in Serbia [2]. Summary by Sections Performance Review - The company reported a revenue of 11.8 billion yuan for 2024, with a net profit of 1.3 billion yuan, reflecting a year-on-year decrease of 20.8% [1]. - Q4 revenue was 3.48 billion yuan, up 9.8% year-on-year, while net profit fell by 43.2% to 240 million yuan [1]. Business Analysis - ODM revenue decreased by 0.3% to 9.32 billion yuan, while OBM revenue increased by 34.0% to 2.48 billion yuan [1]. - The Chinese market showed strong growth in ODM, with H2 revenue up 49.6% [1]. - The gross margin decreased to 36.9% due to product mix changes and increased costs [2]. Profit Forecast and Valuation - EPS forecasts for 2025-2027 are 0.24, 0.40, and 0.56 yuan respectively, with corresponding PE ratios of 52, 32, and 22 [3].
思摩尔国际（06969）：基本盘迎改善，第二增长曲线值期待